Australian consumers warned: US FDA investigates dietary supplement for hepatitis outbreak

Posted by AFN Staff Writers on 28th October 2013

Food Standards Australia New Zealand (FSANZ) has alerted consumers to a US Food and Drug Administration (FDA) investigation into dietary supplements labelled OxyELITE Pro.

FSANZ has advised consumers not to use OxyELITE Pro supplements because they are potentially linked to an outbreak of acute non-viral hepatitis in Hawaii.

Australian health authorities have been alerted to be on the lookout for acute cases of non-viral hepatitis. Acute non-viral hepatitis is damage to liver cells from any cause lasting less than six months. It is not contagious and symptoms include fever, fatigue, loss of appetite, nausea, vomiting, abdominal pain, dark urine, clay coloured bowel movements, joint pain, yellow eyes and jaundice.

“Consumers need to exercise caution when using any dietary supplement and should do so under medical supervision,” said Steve McCutcheon, FSANZ Chief Executive Officer.

“People also need to be particularly careful about purchasing products online,” Mr McCutcheon said. “Online products can have unsafe ingredients and consumers can’t be certain they are getting legitimate products,” he said.

“Consumers who experience any health effects as a result of consuming these or any dietary supplements should seek medical advice,” Mr McCutcheon said.

FSANZ said it would continue to liaise with health authorities and food regulatory agencies on the investigation and would update its advice to consumers as necessary.

US FDA investigating safety of OxyELITE Pro